Aurobindo Pharma Ltd
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|
| Revenue | 3,000.64 | 2,877.43 | 2,949.24 |
| Operating Expense | 2,005.13 | 1,975.18 | 2,065.02 |
| Net Profit | 692.23 | 582.07 | 581.37 |
| Net Profit Margin | 23.07% | 20.23% | 19.71% |
| Earning Per Share | 11.92 | 10.02 | 10.10 |
| EBIDTA | 993.38 | 905.39 | 884.53 |
| Effective Tax Rate | 18.28% | 22.50% | 19.70% |
Particulars
Mar 2026
Revenue3,000.64
Operating Expense2,005.13
Net Profit692.23
Net Profit Margin23.07
Earning Per Share11.92
EBIDTA993.38
Effective Tax Rate18.28
